SAHPRA says all cancer medication used in SA meets relevant health standards

JOHANNESBURG - The South African Health Products Regulatory Authority (SAHPRA) said all cancer medication used in the country meets the relevant health standards.

This follows the release of a report into the Lancet Global Health investigational study that found that substandard anti-cancer medications are being sold and marketed in some sub-Saharan African countries.

After the report, SAHPRA started internal processes to verify whether any of the South African-registered medicines might have been affected or implicated.

Spokesperson Yuven Gounden said the authority has found that none of the medicines marketed or sold in Africa are affected by the findings.

"SAHPRA is satisfied that the marketed and registered cancer medicines meet the appropriate specifications. Therefore, no substandard cancer medicines were detected."